QIAGEN AARHUS A/S: Financial statements 2015
CVR: 28305087
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
QIAGEN AARHUS A/S (CVR 28305087) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 70,853,000 and a net result of DKK 21,722,000. Equity in the 2015 report amounted to DKK 24,169,000. The solvency ratio was 18.1%.
- Gross Profit
- DKK 70,853,000
- Profit/Loss
- DKK 21,722,000
- Equity
- DKK 24,169,000
- Total Assets
- DKK 133,782,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 70.9M | 21.7M | 24.2M | - |
| 2012 | - | 30M | 938K | 21.9M | 87 |
Official annual report
How creditworthy is QIAGEN AARHUS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
QIAGEN AARHUS A/S has published its annual report for 2014.
About QIAGEN AARHUS A/S
QIAGEN AARHUS A/S is a Danish company of the type Aktieselskab based in Aarhus C, founded in 2004. The company is registered under the industry Computerprogrammering. The company was previously named CLC BIO A/S and GENIEMATICS A/S. The management consists of Jonas Buur Sinding and Timothy Paul Grabham. The board consists of Axel Backheuer (chair), Magnus Fellenius-Blædel, Martin Kofod Ludvigsen and Philipp Sixt Lothar von Hugo. The company is owned by Qiagen N.v.. The company has 57 employees (2026). In 2025, the company reported a gross profit of DKK 83,701,000 and a net result of DKK 4,914,000 compared with DKK 5,867,000 the year before. Equity in the 2025 report amounted to DKK 76,212,000.